SCHEMBL12379067

SCHEMBL12379067

Cc1cc(C(=O)OCc2ccccc2)c(C)c(C)c1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
TDP1 Q9NUW8 3/20 0.50
PTPN1 P18031 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
TSHR P16473 2/20 0.48
LMNA P02545 2/20 0.48
MAPK1 P28482 2/20 0.48
HPGD P15428 1/20 0.48
CYP3A4 P08684 1/20 0.48
KMT2A Q03164 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
RAB9A P51151 4/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 1/20 0.46
HSP90AA1 P07900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12379065 0.87 PTGER1 (0.53) TDP1PTPN1L3MBTL1LMNAHPGD
SCHEMBL12379069 0.84 GLRA1 (0.52) ALDH1A1TDP1PTPN1L3MBTL1LMNA
SCHEMBL12377619 0.81 TDP1 (0.60) ALDH1A1TDP1PTPN1L3MBTL1LMNA
SCHEMBL16586098 0.79 ALDH1A1 (0.53) ALDH1A1TDP1L3MBTL1TSHRMAPK1
SCHEMBL31354660 0.79 ALDH1A1 (0.64) ALDH1A1TDP1L3MBTL1TSHRLMNA
SCHEMBL16789584 0.79 ALDH1A1 (0.64) ALDH1A1TDP1L3MBTL1TSHRLMNA
SCHEMBL17172493 0.78 ALDH1A1 (0.58) ALDH1A1TDP1PTPN1L3MBTL1TSHR
SCHEMBL24983831 0.78 TDP1 (0.56) ALDH1A1TDP1PTPN1L3MBTL1TSHR
SCHEMBL30141088 0.78 TDP1 (0.56) ALDH1A1TDP1PTPN1L3MBTL1TSHR
SCHEMBL15716659 0.77 ALDH1A1 (0.67) ALDH1A1TDP1L3MBTL1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999136-B2 Amide compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-16 US disclosed
US-7956010-B2 Amide compound and use thereof for controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-07 US disclosed
US-20100056640-A1 AMIDE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-03-04 US disclosed
US-20100048701-A1 AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING PLANT DISEASES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056640-A1 AMIDE COMPOUND AND USE THEREOF NAT1, AGXT, HAX1 ALDH1A1 2983/4885TDP1 3823/4885PTPN1 2711/4885
US-20100048701-A1 AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING PLANT DISEASES CYC1, CBR3, CBR1 ALDH1A1 2614/4885TDP1 4452/4885PTPN1 1628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.